1. Home
  2. ALKS vs BIO Comparison

ALKS vs BIO Comparison

Compare ALKS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$40.15

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$377.69

Market Cap

10.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKS
BIO
Founded
1987
1952
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
10.1B
IPO Year
2012
1994

Fundamental Metrics

Financial Performance
Metric
ALKS
BIO
Price
$40.15
$377.69
Analyst Decision
Buy
Buy
Analyst Count
14
4
Target Price
$43.43
★ $339.75
AVG Volume (30 Days)
★ 1.7M
242.2K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 142.61
EPS
★ N/A
N/A
Revenue
$1,475,899,000.00
★ $2,583,200,000.00
Revenue This Year
$24.26
$2.74
Revenue Next Year
$4.47
$3.20
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 0.65
52 Week Low
$27.00
$236.73
52 Week High
$55.67
$396.23

Technical Indicators

Market Signals
Indicator
ALKS
BIO
Relative Strength Index (RSI) 25.56 54.04
Support Level $36.25 $364.41
Resistance Level $51.25 $396.23
Average True Range (ATR) 1.45 9.46
MACD -0.46 -1.49
Stochastic Oscillator 7.68 55.13

Price Performance

Historical Comparison
ALKS
BIO

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: